ArticleFrontiers in public health2026
Burden of hearing loss and diagnostic utility of a screening tool in Kazakhstan: insights from national and cross-sectional analyses.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hearing loss is a significant public health concern that is often under recognized globally, with mild impairment accounting for the largest share of the burden. In Kazakhstan, little is known about national patterns of hearing loss or the utility of simple screening tools for detecting it. This study assessed the burden of hearing loss via Global Burden of Disease (GBD) data and evaluated the diagnostic performance of the Hearing Handicap Inventory for Adults-Screening version (HHIA-S) relative to audiometric testing. Methods: We analyzed GBD 2021 data to estimate the prevalence and years lived with disability (YLDs) from 1990 to 2021. Additionally, a cross-sectional survey was conducted among 506 adults recruited from primary healthcare facilities in Astana and nearby areas. All participants completed the HHIA-S questionnaire and underwent audiometric testing. Diagnostic accuracy was assessed via sensitivity, specificity, predictive values, and the area under the ROC curve (AUC). Results: In 2021, the age-standardized prevalence of hearing loss in Kazakhstan was 17,212 per 100,000 population (95% UI: 16,469-18,048), with mild hearing loss accounting for 71.9% of the cases. The YLD rate was 512 per 100,000 (95% UI: 346 s-732), showing stable trends since 1990. In the cross-sectional study, 20% of the participants had audiometrically confirmed hearing loss, with the prevalence rising sharply after the age of 60 years. Women composed 74% of the sample. The HHIA-S demonstrated a sensitivity of 70.2%, a specificity of 94.1%, a positive predictive value of 77.7%, a negative predictive value of 91.6%, and an AUC of 0.82, indicating good diagnostic performance. Conclusion: Hearing loss remains an important but under recognized health problem in Kazakhstan. Integrating simple screening tools such as the HHIA-S into primary care alongside strengthened audiological services and public awareness campaigns could facilitate early detection and reduce the long-term burden of untreated hearing impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.